Audrey Kodja

Audrey Kodja possesses extensive experience in quality assurance and regulatory affairs within the pharmaceutical and chemical sectors. Initial exposure began at WeylChem Group of Companies as a quality control technician intern in 2014. Subsequent roles included internships focused on quality assurance at Givaudan Lavirotte SA and FAREVA, followed by a position as a quality assurance engineer at FAMAR, where responsibilities included investigating quality deviations linked to contaminants and analytical issues. Audrey further advanced quality assurance expertise at Novartis, engaging in lot review, quality deviation approval, and training documentation, along with project management on recurrent deviation reduction initiatives. As a project manager at FAREVA AMBOISE, preparation for FDA inspections was key, while the current role as head of BtoB quality assurance at SUBSTIPHARM involves overseeing quality processes. Educational background includes studies at ESCOM from 2014 to 2016.